However, there has been concern that because the public has heard that the shot is only 72% protective in the US, and the Pfizer and Moderna COVID-19 vaccines are about 95% protective, some will think this is a "second class" vaccine. Experts say those numbers are highly misleading -- and urge people to take whatever shot is first available to them.
Despite J&J's lower efficacy, White said she was comforted to learn that J&J's research included protection against the new variants of the COVID-19 virus. "I want to make sure that I'm protected and I want to make sure that, you know, that we protect others," Muñoz told CNN. "The quicker we reach herd immunity, the quicker we will be able to go back to as normal a life as we possibly can.""I just don't know much about it , so I would rather go with something that's well known," Rocio Mendez told CNN.
"I don't choose to buy Johnson & Johnson products and haven't for a really long time," Watkins told CNN. "And Pfizer was just a good choice."
It’s like that time I couldn’t decide between a cupcake or a brownie. It just eats you up inside
Americans get a choice, Canadians get nothing, thanks JustinTrudeau